Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations

NCT01835665 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01835665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01835665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2013
Completion date
May 31, 2016
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

progranulin mutation carriers